Kurt Miller

27.3k total citations · 3 hit papers
358 papers, 14.7k citations indexed

About

Kurt Miller is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kurt Miller has authored 358 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 222 papers in Pulmonary and Respiratory Medicine, 94 papers in Surgery and 91 papers in Molecular Biology. Recurrent topics in Kurt Miller's work include Prostate Cancer Treatment and Research (157 papers), Prostate Cancer Diagnosis and Treatment (83 papers) and Bladder and Urothelial Cancer Treatments (54 papers). Kurt Miller is often cited by papers focused on Prostate Cancer Treatment and Research (157 papers), Prostate Cancer Diagnosis and Treatment (83 papers) and Bladder and Urothelial Cancer Treatments (54 papers). Kurt Miller collaborates with scholars based in Germany, United States and Canada. Kurt Miller's co-authors include Mark Schrader, Fred Saad, Karim Fizazi, Cora N. Sternberg, Klaus Jung, Neal D. Shore, Hans Krause, Johann S. de Bono, Carsten Stephan and Howard I. Scher and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kurt Miller

350 papers receiving 14.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

2012 3.3k citations Fred Saad, Kurt Miller et al. profile →
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

2009 596 citations Thomas Wiegel, Ursula Steiner et al. profile →
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

2009 524 citations Monika Jung, Hans‐Joachim Mollenkopf et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kurt Miller	9.1k	4.6k	3.5k	2.9k	2.7k	358	14.7k
E. David Crawford	11.4k 1.3×	4.0k 0.9×	3.2k 0.9×	4.0k 1.4×	2.0k 0.8×	284	17.5k
Mitchell C. Benson	8.6k 0.9×	3.9k 0.8×	2.2k 0.6×	2.8k 1.0×	1.2k 0.5×	268	13.3k
Axel S. Merseburger	9.6k 1.1×	5.9k 1.3×	2.6k 0.7×	2.5k 0.8×	1.9k 0.7×	421	14.3k
Steven Joniau	14.5k 1.6×	3.1k 0.7×	2.8k 0.8×	2.9k 1.0×	3.0k 1.1×	458	18.7k
Bertrand Tombal	10.9k 1.2×	1.8k 0.4×	2.6k 0.7×	3.2k 1.1×	3.4k 1.3×	459	14.2k
David G. McLeod	9.7k 1.1×	3.0k 0.7×	2.4k 0.7×	2.5k 0.9×	754 0.3×	271	13.3k
Paul F. Schellhammer	9.5k 1.0×	3.3k 0.7×	1.5k 0.4×	5.0k 1.7×	1.9k 0.7×	274	17.6k
David J. Grignon	14.6k 1.6×	6.0k 1.3×	3.7k 1.1×	3.5k 1.2×	1.1k 0.4×	364	20.8k
Brent A. Blumenstein	5.6k 0.6×	2.8k 0.6×	1.9k 0.5×	3.9k 1.3×	998 0.4×	123	12.0k
Alexandre de la Taille	10.8k 1.2×	5.2k 1.1×	2.6k 0.7×	1.9k 0.6×	807 0.3×	471	15.7k

Countries citing papers authored by Kurt Miller

Since Specialization

Citations

This map shows the geographic impact of Kurt Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Miller more than expected).

Fields of papers citing papers by Kurt Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Miller. The network helps show where Kurt Miller may publish in the future.

Co-authorship network of co-authors of Kurt Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Miller. A scholar is included among the top collaborators of Kurt Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Miller. Kurt Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gratzke, Christian, et al.. (2025). Differential impact of digital therapy on storage and voiding LUTS: A post‐hoc IPSS analysis from the BEST randomized controlled trial. BJUI Compass. 6(10). e70069–e70069. 1 indexed citations

Wiemer, Laura, et al.. (2025). Evaluating the impact of digital therapy for male LUTS: insights from the BEST trial subgroup analysis. World Journal of Urology. 43(1). 660–660.

Grabbert, Markus, et al.. (2025). A Randomized Trial of an App-Based Therapeutic for Lower Urinary Tract Symptoms. NEJM Evidence. 4(4). EVIDoa2400290–EVIDoa2400290. 3 indexed citations

Wiemer, Laura, et al.. (2025). Defining the Minimal Important Difference in International Prostate Symptom Score for Men with Lower Urinary Tract Symptoms Using a Patient-centered Anchor Measure. European Urology Open Science. 81. 44–49. 1 indexed citations

Higano, Celestia S., Sabina Dizdarevic, John Logue, et al.. (2024). Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE). Cancer. 130(11). 1930–1939. 4 indexed citations

Krause, Hans, et al.. (2024). Retrospective analysis of partial cystectomy in patients with muscle-invasive urothelial carcinoma: A German single-center experience. Urologic Oncology Seminars and Original Investigations. 43(3). 188.e1–188.e8. 1 indexed citations

Grün, Arne, et al.. (2024). Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy. Strahlentherapie und Onkologie. 201(1). 36–46. 1 indexed citations

Miller, Kurt, et al.. (2023). Evidence for benefits and risks of tadalafil as a non-prescription medicine: review and evaluation using the Group Delphi technique to achieve consensus amongst clinical experts. Frontiers in Pharmacology. 14. 1254706–1254706.

Hofbauer, Sebastian, Frank Friedersdorff, Martin Schostak, et al.. (2023). Follow-Up of Men Who Have Undergone Focal Therapy for Prostate Cancer with HIFU—A Real-World Experience. Journal of Clinical Medicine. 12(22). 7089–7089. 2 indexed citations

10.

Huber, Johannes, Hendrik Borgmann, Kurt Miller, et al.. (2023). Urologie 2030: Die dringende Notwendigkeit die Digitalisierung in der Urologie schon jetzt voranzutreiben um die medizinische Versorgung aufrecht erhalten zu können – ein Expertenkonsens. Aktuelle Urologie. 54(3). 213–219. 1 indexed citations

11.

Harbeck, Nadia, Andreas Schneeweiß, Peter Thuss‐Patience, et al.. (2021). Neoadjuvant and adjuvant end-points in health technology assessment in oncology. European Journal of Cancer. 147. 40–50. 9 indexed citations

12.

Miller, Kurt, et al.. (2017). Interventionelle Studie beim metastasierten, hormonnaiven Prostatakarzinom. Aktuelle Urologie. 48(3). 200–202. 1 indexed citations

13.

Hussain, Maha, Sylvestre Le Moulec, Claude Gimmi, et al.. (2016). Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 22(13). 3192–3200. 48 indexed citations

14.

Maxeiner, Andreas, Ahmed Magheli, Korinna Jöhrens, et al.. (2016). Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensus. British Journal of Urology. 118(5). 750–757. 8 indexed citations

15.

Baumunk, D., Carsten Kempkensteffen, Ursula Steiner, et al.. (2013). Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin. BMC Medical Informatics and Decision Making. 13(1). 83–83. 7 indexed citations

16.

Friedersdorff, Frank, Seven Johannes Sam Aghdassi, Hannes Cash, et al.. (2013). Laparoendoscopic single-site (LESS) varicocelectomy with reusable components: comparison with the conventional laparoscopic technique. Surgical Endoscopy. 27(10). 3646–3652. 9 indexed citations

17.

Meyer, Hellmuth‐Alexander, Monika Jung, Hans‐Joachim Mollenkopf, et al.. (2013). miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome. Journal of Molecular Diagnostics. 15(5). 695–705. 126 indexed citations

18.

Wotschofsky, Zofia, Hellmuth‐Alexander Meyer, Monika Jung, et al.. (2012). Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas. International Journal of Biological Sciences. 8(10). 1363–1374. 76 indexed citations

19.

Crawford, E. David, Bertrand Tombal, Kurt Miller, et al.. (2011). A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer. The Journal of Urology. 186(3). 889–897. 118 indexed citations

20.

Catchpole, Gareth, Alexander Platzer, Cornelia Weikert, et al.. (2009). Metabolic profiling reveals key metabolic features of renal cell carcinoma. Journal of Cellular and Molecular Medicine. 15(1). 109–118. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact